Some chemweb subscribers
may be interested in this tutorial. Wendy
Dr. Wendy A. Warr
Wendy Warr &
Associates
Tel./fax +44 (0)1477
533837
wendy@warr.com
http://www.warr.com
-----Original Message-----
From: Jim MacNeil
[mailto:jimm@healthtech.com]
Sent:
To: Wendy
Subject: Discover How The Semantic
Web Can Integrate and Maximize The Silos of Information in Your Research
Dear Wendy,
On
This unique tutorial is designed for managers and team
leaders who struggles to unite data from disparate resources. Attend
this tutorial and find out how the semantic web can integrate and
maximize the silos of information in your . This powerful
tool has applications across many life science arenas including R&D,
project prioritization, clinical trials, translational medicine, and
personalized medicine.
Presenters Include:
Dr. Eric Neumann, Life Science Expert, (W3C)
Dr. Dennis Quan, Research Staff Member, IBM Watson Research,
Tonya Hongsermeier, Medical Decision-Support
Systems, Partners HealthCare
Prof. Mark Musen,
Matt Shanahan, CMO, Teranode Corporation
John
Wilbanks, Executive Director of Science Commons
W3C's newly formed Semantic Web for Healthcare and
Life Sciences Interest Group (HCLSIG) is tasked to identify and propose high
impact uses and best practices of semantic web (SW) technologies. Issues around
clinical trials and safety need to be addressed in innovative ways that
leverage intelligent standards that can cover many needs. HCLSIG will sponsor
discussions of these topics, work with specific consortia, and demonstrate proof-of-concepts
and value through its network of technical members. Basics of SW will be
presented here as well as working demonstrations by organizations and
vendors. Click here
to register for this upcoming tutorial.
Sincerely,
Jim MacNeil
Senior Director of Marketing
Cambridge
Healthtech Institute
P.S. The Semantic Web Applications for Drug Discovery and Development Tutorial
is a pre-conference of the Molecular Medicine Tri-Conference. Visit www.Tri-Conference.com for complete
details on this year's event.
CHI,
If the above information is not of interest to you, please disregard and
we apologize for any inconvenience
this may have caused. To be removed from further emails, click here or
go to www.chiresource.com/remove